生命科学资讯

NHS 'FIT' bowel cancer test reduced unnecessary referrals as cancer numbers remain stable

Novo's CEO 'wishes Pfizer luck' with Metsera drug, but still seeks own monthly GLP-1

Amgen advances toward lupus redemption while gastric cancer candidate struggles

Embattled Novo Nordisk considers buying a monthly GLP-1 to bolster portfolio

Thermo Fisher Scientific Inc. $TMO Shares Sold by Alta Capital Management LLC - MarketBeat

Mediolanum International Funds Ltd Makes New $914,000 Investment in Illumina, Inc. $ILMN - MarketBeat

Barclays Reaffirms Their Buy Rating on Lonza Group Ltd (LONN) - The Globe and Mail

10x Genomics (NASDAQ:TXG) Given Average Recommendation of "Hold" by Analysts - MarketBeat

Rate Hike: Can 10x Genomics Inc grow without dilution - July 2025 Summary & High Return Trade Guides - baoquankhu1.vn

How one family’s cancer story turned into hope for millions - Illumina

What Catalysts Are Shifting The Illumina (ILMN) Story For 2026 And Beyond - Yahoo Finance

FDA seeks withdrawal of Amgen's Tavneos, company says it won't pull drug

UK’s health department expected to spend £1B in pharma trade deal with US

HHS launches $100M antiviral prize to develop broad-spectrum therapies

NIH turmoil takes center stage as director acknowledges no vaccine-autism link

Lipids challenge ligands to control receptors

San Diego Zoo alliance, Illumina partner on DNA sequencing for Frozen Zoo - Times of San Diego

Novo expects sales to fall in 2026, triggering selloff

Pfizer CEO says pipeline pruning is mostly finished after 6 more early-stage culls, $4.4B in impairment charges

Fledgling biotech Exxel plans $13M IPO to succeed where other FAAH inhibitors have failed